Yang Tao, Zhai Jiale, Li Chenyang, Zeng Lingbing, Li Yiqun, Liu Wenzhi, Meng Yan, Fan Yuding, Huang Zhenyu, Zhou Yong, Jiang Nan
Department of Aquatic Animal Medicine, College of Fisheries, Huazhong Agricultural University, Wuhan 430070, China.
Tongwei Agricultural Development Co., Ltd., Tongwei Co., Ltd., Chengdu 610041, China.
Animals (Basel). 2025 Mar 12;15(6):803. doi: 10.3390/ani15060803.
The largemouth bass ranavirus (LMBRaV) caused significant mortality and economic loss in the largemouth bass aquaculture industry around the world, including China. Vaccination is an efficient method for virus defense. In this study, an inactivated LMBRaV vaccine was prepared, and the prevention effect as well as the immune responses were analyzed after the primary and the secondary immunization. Compared to the control group, the counts of leucocytes and erythrocytes increased and peaked at day 14 after the primary immunization, and the proportions of leucocytes, including lymphocytes, monocytes, and neutrophils, were also up-regulation after the primary immunization. Serum neutralizing antibody titers increased and peaked (1:128) at day 28 after the primary immunization. Following the secondary immunization, antibody titers were increased to a higher level (1:512) at 28 days after the secondary immunization. Quantitative real-time PCR analysis demonstrated varying degrees of up-regulation of , , , and transcriptions in the head kidney, which showed that innate and adaptive immune responses were both induced after the primary and the secondary immunization. After challenge with LMBRaV, the relative percent survival rates (RPS) for primary and secondary immunization with inactivated LMBRaV vaccine were determined to be 62.92% and 95.51%, respectively. Therefore, this study suggests that utilizing an inactivated LMBRaV vaccine could induce efficient immune responses and antibody, which might provide a potential efficient countermeasure for LMBRaV prevention.
大口黑鲈呼肠孤病毒(LMBRaV)在包括中国在内的全球大口黑鲈养殖业中造成了重大死亡和经济损失。疫苗接种是抵御病毒的有效方法。在本研究中,制备了一种灭活的LMBRaV疫苗,并在初次和二次免疫后分析了其预防效果以及免疫反应。与对照组相比,初次免疫后白细胞和红细胞数量增加,并在第14天达到峰值,包括淋巴细胞、单核细胞和中性粒细胞在内的白细胞比例在初次免疫后也上调。血清中和抗体滴度在初次免疫后第28天升高并达到峰值(1:128)。二次免疫后,抗体滴度在二次免疫后28天升至更高水平(1:512)。定量实时PCR分析表明,头肾中、、和转录本有不同程度的上调,这表明初次和二次免疫后均诱导了先天性和适应性免疫反应。在用LMBRaV攻毒后,灭活LMBRaV疫苗初次和二次免疫的相对存活率(RPS)分别确定为62.92%和95.51%。因此,本研究表明,使用灭活的LMBRaV疫苗可以诱导有效的免疫反应和抗体,这可能为预防LMBRaV提供一种潜在的有效对策。